Concepedia

Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma

Raphaël Maréchal, Jean‐Baptiste Bachet, John R. Mackey, Cécile Dalban, Pieter Demetter, Kathryn Graham, Anne Couvelard, Magali Svrcek, Armelle Bardier–Dupas, Pascal Hammel,

Gastroenterology · 2012 · 238 citations · 33 references

DOIFull text

Open access

Concepts

References

33

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

, , +13

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

Helmut Oettle, Stefan Post, P. Neuhaus et al. · JAMA · 2007 · 2.4K citations

, , +13

REporting recommendations for tumour MARKer prognostic studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · British Journal of Cancer · 2005 · 1.4K citations · Full text

, , +10

Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

John P. Neoptolemos, Deborah Stocken, Claudio Bassi et al. · JAMA · 2010 · 1.4K citations

, , +17